# Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence

**Authors:** Brian M. Ross

PMC · DOI: 10.3389/frai.2025.1589086 · Frontiers in Artificial Intelligence · 2025-06-04

## TL;DR

This paper explores how AI can mimic the effects of psychedelics on the brain to enhance human creativity.

## Contribution

The paper introduces a novel framework for integrating psychedelic-inspired cognitive mechanisms into AI systems to boost creativity.

## Key findings

- Psychedelics alter brain function, particularly the Default Mode Network, to enhance creativity.
- AI can replicate these effects by introducing novel associations and unconscious cognitive shifts.
- Carefully designed AI systems could serve as cognitive catalysts for innovative problem-solving.

## Abstract

Psychedelics, such as LSD and psilocybin, disrupt entrenched cognitive patterns by facilitating novel insights and new associations. This paper considers how AI can potentially mimic these psychedelic-induced cognitive disruptions to augment and enhance human creativity. Psychedelics likely enhance creativity by altering brain function, notably the activity of the Default Mode Network, which leads to changes in cognition. Psychologically, they may reduce latent inhibition, increase divergent thinking, and promote implicit learning. Similarly, AI systems can replicate these creative enhancements by introducing novel associations, reframing familiar information, and facilitating unconscious cognitive shifts. The risks associated with AI use are also compared to psychedelics, including dependency, ethical concerns, and homogenization of outputs due to bias. Integrating the cognitive mechanisms activated by psychedelics into AI design provides promising pathways for creativity enhancement. Carefully designed AI could act as a cognitive catalyst, fostering innovative thought processes and adaptive problem-solving while addressing identified ethical and practical concerns.

## Linked entities

- **Chemicals:** LSD (PubChem CID 3981), psilocybin (PubChem CID 10624)

## Full-text entities

- **Diseases:** cognitive disruptions (MESH:D003072)
- **Chemicals:** LSD (MESH:D008238), psilocybin (MESH:D011562)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12174950/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC12174950/full.md

---
Source: https://tomesphere.com/paper/PMC12174950